JPRN-UMIN000012162已完成1 期
Adoptive immunotherapy using donor liver NK cells for preventing recurrence of hepatocellular carcinoma after liver transplantation - Liver NK cell immunotherapy for liver transplant patients with HCC
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No HCC patients
研究者
相似试验
招募中
不适用
Adoptive immunotherapy using donor liver graft derived natural killer (NK) cells for preventing severe infection after liver transplantatiodecompensated liver cirrhosis patients who will receive liver transplantationJPRN-UMIN000019183Hiroshima University37
已完成
2 期
Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)NSCLC Stage IIIA/BNCT02118415Technical University of Munich13
招募中
1 期
Donor NK cell infusion for patients after allogeneic hematopoietic stem cell transplantatioacute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, chronic myelogenous leukemiaJPRN-UMIN000005138Hematology, Hyogo College of Medicine9
未知
1 期
Immunotherapy with NK cellsClinical study to investigate safety and efficacy on NK cells to health and cancerJPRN-UMIN000002134Kuramae clinic15
进行中（未招募）
1 期
Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with Non-Small Cell Lung Cancer (NSCLC) after radiochemotherapy (RCT)EUCTR2008-002130-30-DETechnische Universität München Fakultät für Medizin90